Myriam Visschedijk

Myriam Visschedijk has extensive experience in quality management within the pharmaceutical and life sciences industries. Currently serving as the Site Quality Head Bern a.i. and Director at Johnson & Johnson since March 2016, Myriam previously held roles at Abbott as Head QA Development, where responsibilities included overseeing quality activities for drug product development and clinical supplies. Myriam's experience also includes serving as QA Liaison for Vaccines and Fenofibrates at Solvay Pharmaceuticals, where facilitation of quality-related activities was emphasized, and as Head of Quality for CMC at Solvay, focusing on compliance and oversight. Early career experiences include roles at TNO overseeing quality systems and implementing ISO certifications and positions in scientific and quality capacities at the Food Inspection Service. Myriam Visschedijk holds a Master’s degree in Chemistry from Utrecht University.